Advisor Resource Council Co Diagnostics, Inc. Transaction History

Advisor Resource Council

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$3.76 - $6.29 $754,673 - $1.26 Million	-200,711 Reduced 76.21%	62,647 $351,000
Q1 2022 Apr 20, 2022	SELL	$5.03 - $9.61 $166,372 - $317,860	-33,076 Reduced 11.16%	263,358 $1.63 Million
Q3 2021 Nov 16, 2021	BUY	$7.48 - $11.38 $149,600 - $227,600	20,000 Added 7.24%	296,434 $2.88 Million
Q2 2021 Aug 19, 2021	BUY	$7.16 - $9.56 $1.96 Million - $2.62 Million	274,153 Added 12018.98%	276,434 $2.28 Million
Q2 2021 Aug 13, 2021	BUY	$7.16 - $9.56 $16,331 - $21,806	2,281 New	2,281 $18,000

4.3M

48.2K

53.3K

Ticker CODX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 33,781,000
Market Cap $35.8M
Description
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...

Get notified when there are updates to the investment portfolio of Advisor Resource Council, based on Form 13F filings with the SEC.

Stay updated on Advisor Resource Council with notifications on news.